176 related articles for article (PubMed ID: 29634317)
1. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
[TBL] [Abstract][Full Text] [Related]
2. NSD3S stabilizes MYC through hindering its interaction with FBXW7.
Gonzalez-Pecchi V; Kwan AK; Doyle S; Ivanov AA; Du Y; Fu H
J Mol Cell Biol; 2020 Jul; 12(6):438-447. PubMed ID: 31638140
[TBL] [Abstract][Full Text] [Related]
3. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
Yang X; Fan D; Troha AH; Ahn HM; Qian K; Liang B; Du Y; Fu H; Ivanov AA
Bioorg Med Chem; 2021 Sep; 45():116324. PubMed ID: 34333394
[TBL] [Abstract][Full Text] [Related]
5. A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4-SMAD3-DNA complex.
Ouyang W; Li Q; Niu Q; Qui M; Fu H; Du Y; Mo X
J Mol Cell Biol; 2024 Apr; 15(11):. PubMed ID: 37968137
[TBL] [Abstract][Full Text] [Related]
6. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
[TBL] [Abstract][Full Text] [Related]
7. A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors.
Du Y; Fu RW; Lou B; Zhao J; Qui M; Khuri FR; Fu H
Assay Drug Dev Technol; 2013 Jul; 11(6):367-81. PubMed ID: 23906346
[TBL] [Abstract][Full Text] [Related]
8. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2.
Wyhs N; Walker D; Giovinazzo H; Yegnasubramanian S; Nelson WG
J Biomol Screen; 2014 Aug; 19(7):1060-9. PubMed ID: 24608100
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.
Cicka D; Niu Q; Qui M; Qian K; Miller E; Fan D; Mo X; Ivanov AA; Sarafianos SG; Du Y; Fu H
J Mol Cell Biol; 2023 Aug; 15(3):. PubMed ID: 36921991
[TBL] [Abstract][Full Text] [Related]
10. A Dual Readout Assay Based on Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer to Screen for RSK1 Inhibitors.
Jeong EM; Lee MY; Lee JH; Lee BH; Oh KS
Biol Pharm Bull; 2016; 39(4):547-55. PubMed ID: 27040627
[TBL] [Abstract][Full Text] [Related]
11. In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.
Qin Q; Knapinska A; Dobri N; Madoux F; Chase P; Hodder P; Petrukhin K
J Ocul Pharmacol Ther; 2013 Apr; 29(3):298-309. PubMed ID: 23098562
[TBL] [Abstract][Full Text] [Related]
12. A novel high-throughput screening assay for discovery of molecules that increase cellular tetrahydrobiopterin.
Li L; Du Y; Chen W; Fu H; Harrison DG
J Biomol Screen; 2011 Sep; 16(8):836-44. PubMed ID: 21693765
[TBL] [Abstract][Full Text] [Related]
13. Development of a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for the Inhibition of Keap1-Nrf2 Protein-Protein Interaction.
Lee S; Abed DA; Beamer LJ; Hu L
SLAS Discov; 2021 Jan; 26(1):100-112. PubMed ID: 32564647
[TBL] [Abstract][Full Text] [Related]
14. A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting SMAD4-SMAD3-DNA complex.
Ouyang W; Niu Q; Qui M; Fu H; Du Y; Mo X
bioRxiv; 2023 Jul; ():. PubMed ID: 37503208
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.
Böttcher J; Dilworth D; Reiser U; Neumüller RA; Schleicher M; Petronczki M; Zeeb M; Mischerikow N; Allali-Hassani A; Szewczyk MM; Li F; Kennedy S; Vedadi M; Barsyte-Lovejoy D; Brown PJ; Huber KVM; Rogers CM; Wells CI; Fedorov O; Rumpel K; Zoephel A; Mayer M; Wunberg T; Böse D; Zahn S; Arnhof H; Berger H; Reiser C; Hörmann A; Krammer T; Corcokovic M; Sharps B; Winkler S; Häring D; Cockcroft XL; Fuchs JE; Müllauer B; Weiss-Puxbaum A; Gerstberger T; Boehmelt G; Vakoc CR; Arrowsmith CH; Pearson M; McConnell DB
Nat Chem Biol; 2019 Aug; 15(8):822-829. PubMed ID: 31285596
[TBL] [Abstract][Full Text] [Related]
16. The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation.
Rona GB; Almeida DSG; Pinheiro AS; Eleutherio ECA
Oncotarget; 2017 Aug; 8(33):54068-54081. PubMed ID: 28903324
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
18. NSD3: Advances in cancer therapeutic potential and inhibitors research.
Xiu S; Chi X; Jia Z; Shi C; Zhang X; Li Q; Gao T; Zhang L; Liu Z
Eur J Med Chem; 2023 Aug; 256():115440. PubMed ID: 37182335
[TBL] [Abstract][Full Text] [Related]
19. Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor.
Li Y; Ng HQ; Ngo A; Liu S; Tan YW; Kwek PZ; Hung AW; Joy J; Hill J; Keller TH; Kang C
Biomol NMR Assign; 2017 Oct; 11(2):225-229. PubMed ID: 28808922
[TBL] [Abstract][Full Text] [Related]
20. TR-FRET cellular assays for interrogating posttranslational modifications of histone H3.
Machleidt T; Robers MB; Hermanson SB; Dudek JM; Bi K
J Biomol Screen; 2011 Dec; 16(10):1236-46. PubMed ID: 21972037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
